KRAS Gene Mutation Negative
1 clinical trials · Condition
◉ Watch KRAS Gene Mutation Negative
| Record | Firm | Date |
|---|---|---|
| Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal Cancer (NCT04117945) | Academic and Community Cancer Research United | 2020-03-03 |
Track KRAS Gene Mutation Negative automatically
Every clearance here is in the API, with alerts when new ones post.